Found: 56
Select item for more details and to access through your institution.
Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivation.
- Published in:
- Prostate, 2002, v. 50, n. 4, p. 203, doi. 10.1002/pros.10049
- By:
- Publication type:
- Article
Use of nude mouse xenograft models in prostate cancer research.
- Published in:
- Prostate, 2000, v. 43, n. 4, p. 263, doi. 10.1002/1097-0045(20000601)43:4<263::AID-PROS5>3.0.CO;2-I
- By:
- Publication type:
- Article
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-i in formalin-fixed, paraffin-embedded prostatic cancer tissues.
- Published in:
- Prostate, 1995, v. 27, n. 3, p. 154, doi. 10.1002/pros.2990270306
- By:
- Publication type:
- Article
Imaging preclinical tumour models: improving translational power.
- Published in:
- Nature Reviews Cancer, 2014, v. 14, n. 7, p. 481, doi. 10.1038/nrc3751
- By:
- Publication type:
- Article
Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.877613
- By:
- Publication type:
- Article
Radiolabeled Bombesin Analogs.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5766, doi. 10.3390/cancers13225766
- By:
- Publication type:
- Article
Patient-Derived Xenograft Models in Cancer Research.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1593, doi. 10.3390/cancers11101593
- By:
- Publication type:
- Article
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 6, p. 10787, doi. 10.1002/jcb.28370
- By:
- Publication type:
- Article
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 11, p. 1572, doi. 10.3390/biom11111572
- By:
- Publication type:
- Article
Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 10, p. 1377, doi. 10.3390/cells12101377
- By:
- Publication type:
- Article
Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 22, p. 3632, doi. 10.3390/cells11223632
- By:
- Publication type:
- Article
Loss of SLCO1B3 drives taxane resistance in prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
- Published in:
- Prostate, 2022, v. 82, n. 5, p. 505, doi. 10.1002/pros.24297
- By:
- Publication type:
- Article
Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response.
- Published in:
- Prostate, 2019, v. 79, n. 4, p. 390, doi. 10.1002/pros.23745
- By:
- Publication type:
- Article
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models.
- Published in:
- Prostate, 2018, v. 78, n. 16, p. 1262, doi. 10.1002/pros.23701
- By:
- Publication type:
- Article
Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA‐targeted Pten knockout mouse prostate cancer (MuCaP) model.
- Published in:
- Prostate, 2018, v. 78, n. 13, p. 1013, doi. 10.1002/pros.23659
- By:
- Publication type:
- Article
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
- Published in:
- Prostate, 2013, v. 73, n. 15, p. 1636, doi. 10.1002/pros.22655
- By:
- Publication type:
- Article
Genetic alterations and changes in expression of histone demethylases in prostate cancer.
- Published in:
- Prostate, 2010, v. 70, n. 8, p. 889, doi. 10.1002/pros.21123
- By:
- Publication type:
- Article
Screening of genetic and expression alterations of SRC1 gene in prostate cancer.
- Published in:
- Prostate, 2006, v. 66, n. 13, p. 1391, doi. 10.1002/pros.20427
- By:
- Publication type:
- Article
Re: Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Capivasertib combines with docetaxel to enhance anti-tumour activity through inhibition of AKT-mediated survival mechanisms in prostate cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 8, p. 1377, doi. 10.1038/s41416-024-02614-w
- By:
- Publication type:
- Article
Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
- Published in:
- British Journal of Cancer, 2020, v. 123, n. 12, p. 1715, doi. 10.1038/s41416-020-01105-y
- By:
- Publication type:
- Article
Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 11, p. 3627, doi. 10.1007/s00259-022-05821-w
- By:
- Publication type:
- Article
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1339, doi. 10.1007/s00259-020-05057-6
- By:
- Publication type:
- Article
Do androgens control the uptake of F-FDG, C-choline and C-acetate in human prostate cancer cell lines?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 10, p. 1842, doi. 10.1007/s00259-011-1861-6
- By:
- Publication type:
- Article
GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1199432
- By:
- Publication type:
- Article
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 4, p. 506, doi. 10.1002/(SICI)1097-0215(19991112)83:4<506::AID-IJC12>3.0.CO;2-0
- By:
- Publication type:
- Article
Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023144
- By:
- Publication type:
- Article
Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016332
- By:
- Publication type:
- Article
Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013500
- By:
- Publication type:
- Article
The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 7, p. 499, doi. 10.1002/gcc.20873
- By:
- Publication type:
- Article
High‐resolution array comparative genomic hybridization of chromosome arm 8q: Evaluation of genetic progression markers for prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 44, n. 4, p. 438, doi. 10.1002/gcc.20259
- By:
- Publication type:
- Article
Darolutamide does not interfere with OATP‐mediated uptake of docetaxel.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 2, p. 314, doi. 10.1002/ijc.34922
- By:
- Publication type:
- Article
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 12, p. 2826, doi. 10.1002/ijc.25000
- By:
- Publication type:
- Article
Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 2, p. 221, doi. 10.1002/ijc.21201
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga‐SB3 PET/CT‐imaging of primary prostate cancer in therapy‐ naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapy-naive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
GRPr antagonist <sup>68</sup>Ga-SB3 PET/CT-imaging of primary prostate cancer in therapynaive patients.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258814
- By:
- Publication type:
- Article
NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5863, doi. 10.3390/ijms21165863
- By:
- Publication type:
- Article
Awe and anxiety for cancer cells: connecting scientists and patients in a holistic approach of metastasis research.
- Published in:
- Research Involvement & Engagement, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40900-023-00498-3
- By:
- Publication type:
- Article
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices.
- Published in:
- Scientific Reports, 2015, p. 17187, doi. 10.1038/srep17187
- By:
- Publication type:
- Article
The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 11, p. 560, doi. 10.3390/pharmaceutics11110560
- By:
- Publication type:
- Article